Implication of Transcriptional Repression in Compound C-induced Apoptosis in Cancer Cells
Overview
General Medicine
Authors
Affiliations
Compound C, a well-known inhibitor of AMP-activated protein kinase (AMPK), has been reported to induce apoptosis in some types of cells. However, the underlying mechanisms remain largely unclear. Using a DNA microarray analysis, we found that the expression of many genes was downregulated upon treatment with compound C. Importantly, compound C caused transcriptional repression with the induction of p53, a well-known marker of transcriptional stress response, in several cancer cell lines. Compound C did not induce the phosphorylation of p53 but dramatically increased the protein level of p53 similar to some other transcriptional inhibitors, including 5,6-dichloro-1-β-D-ribobenzimidazole (DRB). Consistent with previous reports, we found that compound C initiated apoptotic death of cancer cells in an AMPK-independent manner. Similar to DRB and actinomycin D (ActD), two classic transcription inhibitors, compound C not only resulted in the loss of Bcl-2 and Bcl-xl protein but also induced the phosphorylation of eukaryotic initiation factor-alpha (eIF2α) on Ser51. Hence, the phosphorylation of eIF2α might be a novel marker of transcriptional inhibition. It is noteworthy that compound C-mediated apoptosis of cancer cells is correlated with decreased expression of Bcl-2 and Bcl-xl and the phosphorylation of eIF2α on Ser51. Remarkably, compound C exhibits potent anticancer activities in vivo. Taken together, our data suggest that compound C may be an attractive candidate for anticancer drug development.
Mashayekhi-Sardoo H, Rezaee R, Yarmohammadi F, Karimi G Biol Trace Elem Res. 2024; .
PMID: 39212819 DOI: 10.1007/s12011-024-04351-w.
AMPK: The energy sensor at the crossroads of aging and cancer.
Penugurti V, Manne R, Bai L, Kant R, Lin H Semin Cancer Biol. 2024; 106-107:15-27.
PMID: 39197808 PMC: 11625618. DOI: 10.1016/j.semcancer.2024.08.002.
AMPK inhibitor, compound C, inhibits coronavirus replication in vitro.
Jang M, Park R, Yamamoto A, Park Y, Park Y, Lee S PLoS One. 2023; 18(10):e0292309.
PMID: 37788269 PMC: 10547180. DOI: 10.1371/journal.pone.0292309.
Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem-like cells.
Liu Z, Shan S, Yuan Z, Wu F, Zheng M, Wang Y EMBO Rep. 2022; 24(2):e54006.
PMID: 36416244 PMC: 9900345. DOI: 10.15252/embr.202154006.
Hasei S, Yamamotoya T, Nakatsu Y, Ohata Y, Itoga S, Nonaka Y Int J Mol Sci. 2021; 22(8).
PMID: 33919842 PMC: 8070802. DOI: 10.3390/ijms22084040.